Global HIV Diagnostics Market Size, Share, Forecast Report, 2020-2027

Global HIV Diagnostics Market is expected to hold a value of about USD 7,118.26 Million by 2027 and is projected to register a CAGR of 10.6% from 2020 to 2027.
Human immunodeficiency virus (HIV) is an autoimmune disease which affects the immune system similar to other autoimmune diseases and leaves the body susceptible to other diseases and infections. HIV diagnostics are majorly used to test the HIV diseases.

There are large number of different market player for HIV diagnostics that dominates the market, which includes Siemens Healthiness, Roche Diagnostics, Abbott Laboratories, Beckman Coulter, Inc. and many more. The companies are involved in launching new products, technologies, and are undergo strategic collaboration to develop healthcare produces. For instance, on January 2019, Hologic Inc. has received US Food and Drug Administration (FDA) for its Aptima Mycoplasma genitalium assay, used to detect common sexually transmitted infection (STI).
Segmentation

By Product

Consumables: It is the fastest growing market as there is demand for consumable product for every test. The consumables include assays and kits & reagents and other consumables. These products are used to collect, prepare, and examine the patients’ body samples such as blood, tissues, and others. Furthermore, reagents and kits are the most fundamental and critical components used in diagnostic assays and are required in almost every diagnostic assay.
Instruments: It is the largest segment by product in the HIV diagnostics market. The instruments used in HIV diagnosis includes spectroscopy, microscope, cleaning and sterilization and many more instruments for the analysis of the sample.
Software & Services: As more and more researchers entered this new field of study, the need for power tools and software became apparent and therefore led to the development of such tools. The growth of the services segment is attributed to factors such as the increasing focus of key market players on providing efficient diagnostics services to researchers and rising research activities in genomics.
By Test Type

Antibody Tests: It is the most common performed test to detect the presence of HIV antigen. There are different antibody tests which includes HIV-1 screening test, HIV-1 antibody confirmatory tests and HIV-2 & Group O diagnostic tests. The HIV-1 screening test includes Elisa, rapid tests and home access dried blood spots.
HIV-1 Screening Test: It is performed to confirm HIV and also to find out whether the person have HIV-1 or HIV-2.
HIV-1 Antibody Confirmatory Tests: This test is performed to confirms the HIV-1 infection if the person is positive on the first antigen/antibody combination immunoassay test.
HIV-2 & Group O Diagnostic Tests: It is an in vitro chemiluminescent immunoassay (ChLIA) for the qualitative detection of antibodies to HIV-1 (anti-HIV-1) Groups O and M or antibodies to HIV-2 in human plasma and serum specimens. The company like Abbott offers ABBOTT PRISM HIV O Plus assay for this test.
Viral Load Tests: Viral load test are performed to know the amount of HIV genetic material (RNA) in the blood and reports how many copies of the virus are present. Knowing the viral load helps to decrease an infected person's risk of progressing to HIV and also helps to improves long-term health.
CD4 Tests: CD4 are the type of white cells also known as T cells, that helps to treat HIV and AIDs. HIV damages immune system as it targets CD4 cells. The virus attacks the CD4 cells and releases more HIV copies. The normal CD4 count should be from 500 to 1,400 cells per cubic millimeter of blood. To know the amount of CD4 cell in patient this test is performed.
Tests for Early Infant Diagnosis: Dried blood spot (DBS) sample is collected from infants for early infant diagnosis (EID). This test requires only a small amount of blood, the dried sample is easy to store and transport which increases its preference for the diagnosis of HIV.
By End-User

Diagnostic Laboratories: Diagnostic labs are the fastest growing segment by end users. There are number of diagnostic centers specific for the diagnosis of HIV infection. Additionally, during pregnancy HIV test it is mandate to performed HIV test which increase the market growth. The diagnostic laboratories is anticipated the fastest market owing to the presence of advance diagnostic instruments to ensure accuracy of results.
Hospitals: The hospitals accounted for the largest market share by end user and expected to register a healthy CAGR during the forecast period. The growth of this segment is attributed to a growth in hospital visits for the diagnosis and treatment of HIV.
Blood Banks: The increasing surgical procedures requires blood. Before collecting blood from the donor there are number of tests to be performed to ensure the safety that increases the demand for the product.
Others: The other end users includes HIV/AIDs campaigns and research institutes.

Key Players

• Siemens Healthineers (A Division of Siemens AG) (Erlangen, Germany.)
• Roche Diagnostics (Division of Hoffman La Roche Ltd.) (Basel, Switzerland)
• Abbott Laboratories (Chicago, US)
• Beckman Coulter, Inc. (Subsidiary of Danaher Corporation) (California, US)
• Thermo-Fisher Scientific Inc. (Massachusetts, US)
• Merck KGaA (Darmstadt, Germany)
• Becton, Dickinson & Company (New Jersey, US)
• Hologic Inc. (Massachusetts, US)
• Alere Inc. (Massachusetts, US)
• Bio-Rad Laboratorie (California, US)